These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31260264)

  • 41. Fast screening and identification of illegal adulteration in dietary supplements and herbal medicines using molecular networking with deep-learning-based similarity algorithms.
    Sheng Y; Xue Y; Wang J; Liu S; Jiang Y
    Anal Bioanal Chem; 2023 Jul; 415(16):3285-3293. PubMed ID: 37119358
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic study of vardenafil analogues: Pseudovardenafil and hydroxyvardenafil.
    Heo D; Kang JS; Choe S; Lee S; Kim KM; Pyo J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Feb; 1139():121940. PubMed ID: 31978742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure elucidation of thioketone analogues of sildenafil detected as adulterants in herbal aphrodisiacs.
    Reepmeyer JC; d'Avignon DA
    J Pharm Biomed Anal; 2009 Jan; 49(1):145-50. PubMed ID: 19042103
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LC-MSsim--a simulation software for liquid chromatography mass spectrometry data.
    Schulz-Trieglaff O; Pfeifer N; Gröpl C; Kohlbacher O; Reinert K
    BMC Bioinformatics; 2008 Oct; 9():423. PubMed ID: 18842122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimization and Comparison of Information-Dependent Acquisition (IDA) to Sequential Window Acquisition of All Theoretical Fragment Ion Spectra (SWATH) for High-Resolution Mass Spectrometry in Clinical Toxicology.
    Whitman JD; Lynch KL
    Clin Chem; 2019 Jul; 65(7):862-870. PubMed ID: 30996055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Software-assisted automated detection and identification of "unknown" analogues of benzodiazepines in liquid chromatography mass spectrometry analysis.
    Marder D; Gutman O; Bretler U; Katz Y; Yishai-Aviram L; Drug E
    Rapid Commun Mass Spectrom; 2024 Oct; 38(19):e9883. PubMed ID: 39103749
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a specific fragment pattern-based quadrupole-Orbitrap mass spectrometry method to screen adulterated products of phosphodiesterase-5 inhibitors and their analogues.
    Lee JH; Park HN; Park S; Lee YM; Kang H
    Sci Justice; 2019 Jul; 59(4):433-441. PubMed ID: 31256815
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LC-ESI-MS/MS analysis of phosphodiesterase-5 inhibitors and their analogues in foods and dietary supplements in Korea.
    Jeong JH; Lee JH; Kim HJ; Park HJ; Hwang IS; Han KM; Yoon CY; Cho S; Kim WS
    Food Addit Contam Part B Surveill; 2016; 9(1):1-8. PubMed ID: 25263347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New treatment options for erectile dysfunction in patients with diabetes mellitus.
    Basu A; Ryder RE
    Drugs; 2004; 64(23):2667-88. PubMed ID: 15537369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: results of a European multicenter, open-label study of patient preference.
    Ströberg P; Murphy A; Costigan T
    Clin Ther; 2003 Nov; 25(11):2724-37. PubMed ID: 14693300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spectral entropy outperforms MS/MS dot product similarity for small-molecule compound identification.
    Li Y; Kind T; Folz J; Vaniya A; Mehta SS; Fiehn O
    Nat Methods; 2021 Dec; 18(12):1524-1531. PubMed ID: 34857935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the erectile dysfunction observational study (EDOS).
    Martin-Morales A; Haro JM; Beardsworth A; Bertsch J; Kontodimas S;
    Eur Urol; 2007 Feb; 51(2):541-50; discussion 550. PubMed ID: 17084518
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The molecular basis for the selectivity of tadalafil toward phosphodiesterase 5 and 6: a modeling study.
    Huang YY; Li Z; Cai YH; Feng LJ; Wu Y; Li X; Luo HB
    J Chem Inf Model; 2013 Nov; 53(11):3044-53. PubMed ID: 24180640
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patients' preference in the treatment of erectile dysfunction: a critical review of the literature.
    Morales AM; Casillas M; Turbi C
    Int J Impot Res; 2011; 23(1):1-8. PubMed ID: 21191396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MZDASoft: a software architecture that enables large-scale comparison of protein expression levels over multiple samples based on liquid chromatography/tandem mass spectrometry.
    Ghanat Bari M; Ramirez N; Wang Z; Zhang JM
    Rapid Commun Mass Spectrom; 2015 Oct; 29(19):1841-8. PubMed ID: 26331936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Mulhall JP; McLaughlin TP; Harnett JP; Scott B; Burhani S; Russell D
    J Sex Med; 2005 Nov; 2(6):848-55. PubMed ID: 16422809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Simultaneous determination of yohimbine, sildenafil, vardenafil and tadalafil in dietary supplements using high-performance liquid chromatography-tandem mass spectrometry.
    Zhang Y; Huang Z; Ding L; Yan H; Wang M; Zhu S
    J Sep Sci; 2010 Jul; 33(14):2109-14. PubMed ID: 20533336
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Examination of segmental average mass spectra from liquid chromatography-tandem mass spectrometric (LC-MS/MS) data enables screening of multiple types of protein modifications.
    Liu NY; Lee HH; Chang ZF; Tsay YG
    Anal Chim Acta; 2015 Sep; 892():115-22. PubMed ID: 26388481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methods to Calculate Spectrum Similarity.
    Yilmaz Ş; Vandermarliere E; Martens L
    Methods Mol Biol; 2017; 1549():75-100. PubMed ID: 27975285
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective, randomized, open-label, fixed-dose, crossover study to establish preference of patients with erectile dysfunction after taking the three PDE-5 inhibitors.
    Tolrà JR; Campaña JMC; Ciutat LF; Miranda EF
    J Sex Med; 2006 Sep; 3(5):901-909. PubMed ID: 16942534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.